Exact Mass: 481.10763219999995

Yersiniabactin

C21H27N3O4S3 (481.1163622000001)

A member of the class of thiazolidines that is (4S)-4-methyl-4,5-dihydro-1,3-thiazole-4-carboxylic acid which is substituted at position 2 by a (1S)-1-hydroxy-1-{(4R)-2-[(4R)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl}-2-methylpropan-2-yl group. A siderophore found in the gram-negative bacterium species, Yersinia enterocolitica and Yersinia pestis. D064449 - Sequestering Agents > D002614 - Chelating Agents > D007502 - Iron Chelating Agents

Talampicillin

C24H23N3O6S (481.13074980000005)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CA - Penicillins with extended spectrum D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic Same as: D08557

Cycloprothrin

C26H21Cl2NO4 (481.08475660000005)

6-(Methylsulfonyl)hexyl glucosinolate

C14H27NO11S3 (481.0746192)

6-(Methylsulfonyl)hexyl glucosinolate is present in crucifers. Present in crucifers

Talampicillin

C24H23N3O6S (481.13074980000005)

Yersiniabactin

C21H27N3O4S3 (481.1163622000001)

Glucomalcomiin

C17H23NO11S2 (481.0712488)

Acquisition and generation of the data is financially supported by the Max-Planck-Society

Glucobenzosisymbrin

C17H23NO11S2 (481.0712488)

lynamicin D

C24H17Cl2N3O4 (481.0596062)

Nikkomycin Oz

C19H23N5O10 (481.1444858)

Nikkomycin Ox

C19H23N5O10 (481.1444858)

3-Hydroxy-6-(methylsulfinyl)hexyl glucosinolate

C14H27NO11S3 (481.0746192)

2-(4-Methoxyphenyl)-2,2-dimethylethyl glucosinolate

C18H27NO10S2 (481.10763219999995)

6-Hydroxydelphinidin 3-glucoside

C21H21O13 (481.0982116)

Maybridge4_000191

C22H28ClN3O3S2 (481.1260528000001)

Oprea1_736509

C29H24ClN3O2 (481.1556954)

(1E)-5-methoxy-6-hydroxycinnamenyl-(1->6)-5,6-dihydrosanguinarine|maclekarpine E

C29H23NO6 (481.1525298)

(4Z)-5-{6-O-[(2E)-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enoyl]-beta-glucopyranosylsulfanyl}pent-4-enenitrile

C22H27NO9S (481.1406452000001)

Ala Cys Cys Trp

C20H27N5O5S2 (481.14535320000005)

Ala Cys Trp Cys

C20H27N5O5S2 (481.14535320000005)

Ala Trp Cys Cys

C20H27N5O5S2 (481.14535320000005)

Cys Ala Cys Trp

C20H27N5O5S2 (481.14535320000005)

Cys Ala Trp Cys

C20H27N5O5S2 (481.14535320000005)

Cys Cys Ala Trp

C20H27N5O5S2 (481.14535320000005)

Cys Cys Glu Gln

C16H27N5O8S2 (481.13009819999996)

Cys Cys Gln Glu

C16H27N5O8S2 (481.13009819999996)

Cys Cys Trp Ala

C20H27N5O5S2 (481.14535320000005)

Cys Asp Met Asn

C16H27N5O8S2 (481.13009819999996)

Cys Asp Asn Met

C16H27N5O8S2 (481.13009819999996)

Cys Glu Cys Gln

C16H27N5O8S2 (481.13009819999996)

Cys Glu Gln Cys

C16H27N5O8S2 (481.13009819999996)

Cys Met Asp Asn

C16H27N5O8S2 (481.13009819999996)

Cys Met Asn Asp

C16H27N5O8S2 (481.13009819999996)

Cys Asn Asp Met

C16H27N5O8S2 (481.13009819999996)

Cys Asn Met Asp

C16H27N5O8S2 (481.13009819999996)

Cys Gln Cys Glu

C16H27N5O8S2 (481.13009819999996)

Cys Gln Glu Cys

C16H27N5O8S2 (481.13009819999996)

Cys Trp Ala Cys

C20H27N5O5S2 (481.14535320000005)

Cys Trp Cys Ala

C20H27N5O5S2 (481.14535320000005)

Asp Cys Met Asn

C16H27N5O8S2 (481.13009819999996)

Asp Cys Asn Met

C16H27N5O8S2 (481.13009819999996)

Asp Met Cys Asn

C16H27N5O8S2 (481.13009819999996)

Asp Met Asn Cys

C16H27N5O8S2 (481.13009819999996)

Asp Asn Cys Met

C16H27N5O8S2 (481.13009819999996)

Asp Asn Met Cys

C16H27N5O8S2 (481.13009819999996)

Glu Cys Cys Gln

C16H27N5O8S2 (481.13009819999996)

Glu Cys Gln Cys

C16H27N5O8S2 (481.13009819999996)

Glu Gln Cys Cys

C16H27N5O8S2 (481.13009819999996)

Met Cys Asp Asn

C16H27N5O8S2 (481.13009819999996)

Met Cys Asn Asp

C16H27N5O8S2 (481.13009819999996)

Met Asp Cys Asn

C16H27N5O8S2 (481.13009819999996)

Met Asp Asn Cys

C16H27N5O8S2 (481.13009819999996)

Met Asn Cys Asp

C16H27N5O8S2 (481.13009819999996)

Met Asn Asp Cys

C16H27N5O8S2 (481.13009819999996)

Asn Cys Asp Met

C16H27N5O8S2 (481.13009819999996)

Asn Cys Met Asp

C16H27N5O8S2 (481.13009819999996)

Asn Asp Cys Met

C16H27N5O8S2 (481.13009819999996)

Asn Asp Met Cys

C16H27N5O8S2 (481.13009819999996)

Asn Met Cys Asp

C16H27N5O8S2 (481.13009819999996)

Asn Met Asp Cys

C16H27N5O8S2 (481.13009819999996)

Gln Cys Cys Glu

C16H27N5O8S2 (481.13009819999996)

Gln Cys Glu Cys

C16H27N5O8S2 (481.13009819999996)

Gln Glu Cys Cys

C16H27N5O8S2 (481.13009819999996)

Trp Ala Cys Cys

C20H27N5O5S2 (481.14535320000005)

Trp Cys Ala Cys

C20H27N5O5S2 (481.14535320000005)

Trp Cys Cys Ala

C20H27N5O5S2 (481.14535320000005)

6-(Methylsulfonyl)hexyl glucosinolate

C14H27NO11S3 (481.0746192)

silybin (mixture of silybin a and silybin b)

C25H21O10 (481.11346660000004)

CefixiMe Ethyl Ester Sodium Salt

C18H19N5O7S2 (481.0725864)

methyl 2-[[3-[[(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)amino]carbonyl]-2-hydroxy-1-naphthyl]azo]benzoate

C26H19N5O5 (481.13861240000006)

1H-Pyrrolo[2,3-b]pyridine, 1-[(4-Methylphenyl)sulfonyl]-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3-(2-thiazolyl)-

C23H24BN3O4S2 (481.1301214)

fmoc-l-4-phosphonomethylphenylalanine

C25H24NO7P (481.1290324)

IP-FOXAP

C28H28FeNOP (481.12577980000003)

Mikethrene Yellow 4GF

C30H15N3O4 (481.10625100000004)

1-(METHOXYCARBONYL)-4-PIPERIDINECARBOXYLIC ACID

C23H29Cl2N3O4 (481.15350140000004)

6-[2-[6-(2-dimethylaminoethyl)-4-methoxy-benzo[1,3]dioxol-5-yl]acetyl]-2,3-dimethoxy-benzoic acid

C23H28ClNO8 (481.15033580000005)

Diethyl thiophosphoryl-(Z)-2-(2-aminothiazol-4-yl)-2-(tert-butoxycarbonyl)isopropoxyiminoacetate

C17H28N3O7PS2 (481.11062280000004)

1-Biotinylamino-3,6,9-trioxaundecane-11-bromide

C18H32BrN3O5S (481.12459220000005)

4-METHYLUMBELLIFERYL-2-ACETAMIDO-2-DEOXY-6-SULPHATE-β-D-GLUCOPYRANOSIDE

C18H20NNaO11S (481.065473)

ENLOPLATIN

C13H22N2O5Pt (481.1176492)

Spiclomazine hydrochloride

C22H25Cl2N3OS2 (481.081602)

2-[[4-[(2,6-Dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]imino-3,4-dimethyl-5-thiazolecarboxylic acid ethyl ester

C21H27N3O6S2 (481.13412020000004)

Imidazol-3-ide;2-pyridin-2-ylpyridine;ruthenium(3+)

C23H19N6Ru+2 (481.0714514)

Enloplatin [mart.]

C13H22N2O5Pt (481.1176492)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent C274 - Antineoplastic Agent > C798 - Radiosensitizing Agent > C1450 - Platinum Compound

Cefepime conjugate acid

C19H25N6O5S2+ (481.13277800000003)

J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DE - Fourth-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams

3-Benzoyloxypropyl glucosinolate

C17H23NO11S2 (481.0712488)

3-Amino-4-hydroxybenzoate-adenylate

C17H18N6O9P- (481.0872848000001)

tarocin A

C24H17F6NO3 (481.1112564)

6-[5-[[(5-cyano-4-oxo-6-phenyl-1H-pyrimidin-2-yl)thio]methyl]-2-oxo-1,3-dihydroimidazol-4-yl]-6-oxohexanoic acid ethyl ester

C23H23N5O5S (481.14198280000005)

N-[1-[(4-bromoanilino)-oxomethyl]cyclohexyl]-N-(2-furanylmethyl)-2-pyridinecarboxamide

C24H24BrN3O3 (481.1000934)

4-[[1-[(3,4-Dichlorophenyl)methyl]-3-indolyl]-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-one

C24H21Cl2N5O2 (481.1072226)

3-(1,3-benzodioxol-5-ylmethyl)-7-[1,4-dioxa-8-azaspiro[4.5]decan-8-yl(oxo)methyl]-2-sulfanylidene-1H-quinazolin-4-one

C24H23N3O6S (481.13074980000005)

N-[3-[(2,4-dimethylphenyl)sulfamoyl]-4-methylphenyl]-3-oxo-4H-1,4-benzothiazine-6-carboxamide

C24H23N3O4S2 (481.11299180000003)

N-(3-cyano-6-methyl-4,5,6,7-tetrahydro-1-benzothiophen-2-yl)-5-phenyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxamide

C24H18F3N5OS (481.1184094)

5-bromo-2-methoxy-3-methyl-N-[4-(4-methylsulfonyl-1-piperazinyl)phenyl]benzamide

C20H24BrN3O4S (481.06708040000007)

Ethyl 4,5-dimethyl-2-[[2-(6-methyl-4-oxo-5-phenylthieno[2,3-d]pyrimidin-3-yl)acetyl]amino]thiophene-3-carboxylate

C24H23N3O4S2 (481.11299180000003)

N-[[(2S,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

C22H32BrN3O4 (481.15760520000003)

N-[[(2R,3R)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

C22H32BrN3O4 (481.15760520000003)

N-[[3-bromo-4-[(4-fluorophenyl)methoxy]-5-methoxyphenyl]methyl]-2-[(1-methyl-5-tetrazolyl)thio]ethanamine

C19H21BrFN5O2S (481.05832780000003)

(1S,9R,10R,11R)-N-[(3,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-12-(pyrazine-2-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C24H21F2N5O4 (481.156153)

1-(3-chlorophenyl)-3-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[(2-methylphenyl)sulfonylamino]ethyl]-3-oxanyl]urea

C22H28ClN3O5S (481.1438108000001)

(1R,9S,10S,11S)-N-[(3,5-difluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-12-(pyrazine-2-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C24H21F2N5O4 (481.156153)

N-[[(2S,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

C22H32BrN3O4 (481.15760520000003)

N-[[(2R,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

C22H32BrN3O4 (481.15760520000003)

N-[[(2R,3S)-8-bromo-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

C22H32BrN3O4 (481.15760520000003)

N-[[(2R,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

C22H32BrN3O4 (481.15760520000003)

N-[[(2S,3R)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

C22H32BrN3O4 (481.15760520000003)

N-[[(2S,3S)-8-bromo-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylcyclohexanecarboxamide

C22H32BrN3O4 (481.15760520000003)

6-Hydroxydelphinidin 3-glucoside

C21H21O13+ (481.0982116)

(6R,7S)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C19H25N6O5S2+ (481.13277800000003)

(3-oxo-1H-2-benzofuran-1-yl) (2S,5S,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate

C24H23N3O6S (481.13074980000005)

[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] 2-methoxybenzoate

C18H20N5O9P (481.0998600000001)

cefepime(1+)

C19H25N6O5S2 (481.13277800000003)

The conjugate acid of cefepime.

AGI-6780

C21H18F3N3O3S2 (481.07416340000003)

AGI-6780 that potently and selectively inhibits the tumor-associated mutant IDH2R140Q with IC50 of 23±1.7 nM. AGI-6780 is less potent against IDH2WT with IC50 of 190±8.1 nM.

GSK598809

C22H23F4N5OS (481.1559356)

GSK598809 is a potent and selective dopamine D3 Receptor (DRD3) antagonist, with a pKi of 8.9.

SQLE-IN-1

C24H21F2N5O2S (481.138395)

SQLE-IN-1 (compound 19) is a squalene epoxidase (SQLE) inhibitor. SQLE-IN-1 inhibits the proliferation and migration of Huh7 cells. SQLE-IN-1 inhibits the cell cholesterol generation. SQLE-IN-1 increases the expression of PTEN and inhibits PI3K and AKT[1]. SQLE-IN-1 (compound 19) is a squalene epoxidase (SQLE) inhibitor. SQLE-IN-1 inhibits the proliferation and migration of Huh7 cells. SQLE-IN-1 inhibits the cell cholesterol generation. SQLE-IN-1 increases the expression of PTEN and inhibits PI3K and AKT[1].

UC2288

C20H18ClF6N3O2 (481.09916699999997)

UC2288 is a novel, cell-permeable, and orally active p21 attenuator (relatively selective activity for p21), which is synthesized based Sorafenib (HY-10201). UC2288 decreases p21 mRNA expression independently of p53, and attenuates p21 protein levels with minimal effect on p21 protein stability. UC2288 has no inhibition of VEGFR2 and Raf kinases even at 10 μM[1].

(r)-{[(2s,4s)-2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)butylidene]amino}[(2s,3s,4s,5s)-3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid

C19H23N5O10 (481.1444858)

{[2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)butylidene]amino}[5-(4-formyl-2-hydroxyimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]acetic acid

C19H23N5O10 (481.1444858)

2-methoxy-4-[(1e)-2-[(23r)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-yl]ethenyl]phenol

C29H23NO6 (481.1525298)

(4s)-2-[(1s)-1-hydroxy-2-methyl-1-[(4r)-2-[(4r)-2-[(1e)-6-oxocyclohexa-2,4-dien-1-ylidene]-1,3-thiazolidin-4-yl]-1,3-thiazolidin-4-yl]propan-2-yl]-4-methyl-5h-1,3-thiazole-4-carboxylic acid

C21H27N3O4S3 (481.1163622000001)

[(z)-[(4s)-4-hydroxy-7-[(r)-methanesulfinyl]-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}heptylidene]amino]oxysulfonic acid

C14H27NO11S3 (481.0746192)

[(e)-(7-methanesulfonyl-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}heptylidene)amino]oxysulfonic acid

C14H27NO11S3 (481.0746192)

5,6,7-trihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)-1λ⁴-chromen-1-ylium

[C21H21O13]+ (481.0982116)

{[4-(benzoyloxy)-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene]amino}oxysulfonic acid

C17H23NO11S2 (481.0712488)

[(e)-{4-[(e)-benzoyloxy]-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}butylidene}amino]oxysulfonic acid

C17H23NO11S2 (481.0712488)

(4s)-2-[(1s)-1-hydroxy-1-[(2r,4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl]-2-methylpropan-2-yl]-4-methyl-5h-1,3-thiazole-4-carboxylic acid

C21H27N3O4S3 (481.1163622000001)

(r)-{[(2r,4s)-2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)butylidene]amino}[(2s,3r,4s,5r)-5-(4-formyl-2-hydroxyimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]acetic acid

C19H23N5O10 (481.1444858)

(4r)-2-[(1s)-1-hydroxy-1-[(2r,4r)-2-[(4r)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl]-2-methylpropan-2-yl]-4-methyl-5h-1,3-thiazole-4-carboxylic acid

C21H27N3O4S3 (481.1163622000001)

{[2-amino-1,4-dihydroxy-4-(5-hydroxypyridin-2-yl)butylidene]amino}[3,4-dihydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)oxolan-2-yl]acetic acid

C19H23N5O10 (481.1444858)

(4s)-2-(1-hydroxy-1-{2-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-thiazol-4-yl]-1,3-thiazolidin-4-yl}-2-methylpropan-2-yl)-4-methyl-5h-1,3-thiazole-4-carboxylic acid

C21H27N3O4S3 (481.1163622000001)

2-methoxy-4-(2-{24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaen-23-yl}ethenyl)phenol

C29H23NO6 (481.1525298)